Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia
Clinical trial NCT03817398 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03817398
- Sponsor
- Children's Oncology Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-08
- Primary completion
- 2026-09-30
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.